International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7874403
Original Article
Hematological Study of Pancytopenia in Patients Attending in Tertiary Care Hospital at, SKMCH, Muzaffarpur, Bihar
 ,
 ,
 ,
Published
April 28, 2023
Abstract
Objective: The aim of present study was designed to ascertain the percentage of occurrence and cause of pancytopenia. Materials and Methods: A total of 232 patients fulfilled the criteria for Pancytopenia. Out of them 186 were subjected to Bone marrow examination and regular follow up and we have restricted our studies with them. Results: Most of the patients were ranged between 12 to 75 years of age with male preponderance and were seen in third decade of life. Commonest cause of pancytopenia was megaloblastic anemia Seen in 148 cases (79.56%) followed by hypersplenism due to kala-azar in 18 cases (9.67%) and in non-hodgkin'slymphoma 03(1.61%) cases. Pallor was seen in most cases. Massive splenomegaly was seen in kala azar, malaria. Hepatosplenomegaly was seen in many cases of megaloblastic anemia. In peripheral blood smear examination anisopoikilocytosis was the predominant finding of megaloblastic anemia, hypersplenism due to kala- azar and malaria. Conclusion: Bone marrow examination was of diagnostic value to the patients with pancytopenia. So, any case of anemia detailed study on physical finding, peripheral blood picture and for conformation bone marrow aspiration was done.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1446 Views
324 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved